Filana Therapeutics (FLNA) CEO Barry Richard Buys 93,091 Shares

What Happened Barry Richard, President & CEO and a director of Filana Therapeutics (FLNA), made an open-market purchase of 93,091 shares on September 28, 2026. The reported weighted-average price was $0.84 per share, for a total transaction value of approximately $78,196. This was a purchase (insider buy), which some investors view as a more informative signal than routine sales.

Key Details

• Transaction date: 2026-09-28 (reported on Form 4 filed 2026-09-30).
• Transaction type/code: Open-market purchase (Code P).
• Shares purchased: 93,091 shares; weighted-average price $0.84; total ≈ $78,196.
• Price range: Shares were acquired in multiple trades at $0.82–$0.85 per share (footnote states the $0.84 is a weighted average).
• Shares owned after the transaction: Not specified in the provided filing data.
• Footnote: The reporting person offers to provide, upon request, the number of shares bought at each price within the $0.82–$0.85 range.
• Filing timeliness: Form 4 was filed two days after the transaction date, consistent with standard timely reporting.

Context This was a straightforward open-market purchase by an executive (not an option exercise, gift, or tax-related withholding). Purchases by insiders can be of interest to investors but do not guarantee future company performance; the filing provides a breakdown offer for the multiple trade prices if more detail is needed.